Learn More
BACKGROUND:Patients with chronic hepatitis C are at risk of developing type 2 diabetes mellitus (DM) and impaired fasting glucose (IFG), and this risk may increase among hepatitis C virus (HCV)(More)
OBJECTIVES:To evaluate whether in chronic hepatitis C-positive patients who failed to respond to interferon (IFN) monotherapy a sustained response obtained with retreatment using the combination(More)
BACKGROUND Patients with chronic hepatitis C have an increased risk of diabetes mellitus but the type and risk of developing diabetes-related complications have not yet been evaluated. METHODS In(More)
BACKGROUND There is yet no established treatment for chronic hepatitis C patients non-responder to standard interferon and ribavirin. AIM To evaluate efficacy and safety of(More)